Inhibition of miR-29 by TGF-beta-Smad3 Signaling through Dual Mechanisms Promotes Transdifferentiation of Mouse Myoblasts into Myofibroblasts

MicroRNAs (miRNAs) are non-coding RNAs that regulate gene expression in post-transcriptional fashion, and emerging studies support their importance in regulating many biological processes, including myogenic differentiation and muscle development. miR-29 is a promoting factor during myogenesis but its full spectrum of impact on muscle cells has yet to be explored. Here we describe an analysis of miR-29 affected transcriptome in C2C12 muscle cells using a high throughput RNA-sequencing platform. The results reveal that miR-29 not only functions to promote myogenic differentiation but also suppresses the transdifferentiation of myoblasts into myofibroblasts. miR-29 inhibits the fibrogenic differentiation through down-regulating both extracellular matrix genes and cell adhesion genes. We further demonstrate that miR-29 is under negative regulation by TGF-beta (TGF-β)–Smad3 signaling via dual mechanisms of both inhibiting MyoD binding and enhancing Yin Yang 1 (YY1)-recruited Polycomb association. Together, these results identify miR-29 as a pleiotropic molecule in both myogenic and fibrogenic differentiation of muscle cells.

[1]  T. Pawson,et al.  Deletion of Exon I of SMAD7 in Mice Results in Altered B Cell Responses , 2006, The Journal of Immunology.

[2]  R. Derynck,et al.  TGF‐β‐activated Smad3 represses MEF2‐dependent transcription in myogenic differentiation , 2004, The EMBO journal.

[3]  Chris Albanese,et al.  NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.

[4]  C. Lau,et al.  Smad3 Mediates Cardiac Inflammation and Fibrosis in Angiotensin II–Induced Hypertensive Cardiac Remodeling , 2010, Hypertension.

[5]  M. Rudnicki,et al.  The molecular regulation of myogenesis , 2000, Clinical genetics.

[6]  R. Day,et al.  Myofibroblast Differentiation by Transforming Growth Factor-β1 Is Dependent on Cell Adhesion and Integrin Signaling via Focal Adhesion Kinase* , 2003, The Journal of Biological Chemistry.

[7]  R. Derynck,et al.  Repression of Runx2 function by TGF‐β through recruitment of class II histone deacetylases by Smad3 , 2005, The EMBO journal.

[8]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[9]  Yong Li,et al.  Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. , 2004, The American journal of pathology.

[10]  N. Tjandra,et al.  Structural Basis of Focal Adhesion Localization of LIM-only Adaptor PINCH by Integrin-linked Kinase* , 2009, Journal of Biological Chemistry.

[11]  B. Spiegelman,et al.  Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Kantharidis,et al.  TGF-β Regulates miR-206 and miR-29 to Control Myogenic Differentiation through Regulation of HDAC4 , 2011, The Journal of Biological Chemistry.

[13]  Jeffrey E. Thatcher,et al.  Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis , 2008, Proceedings of the National Academy of Sciences.

[14]  Paul Ahlquist,et al.  MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins , 2008, Proceedings of the National Academy of Sciences.

[15]  P. Muñoz-Cánoves,et al.  Regulation and dysregulation of fibrosis in skeletal muscle. , 2010, Experimental cell research.

[16]  P. Bruni,et al.  Transforming Growth Factor-β1 Induces Transdifferentiation of Myoblasts into Myofibroblasts via Up-Regulation of Sphingosine Kinase-1/S1P3 Axis , 2010, Molecular biology of the cell.

[17]  Gyorgy Hutvagner,et al.  Small RNA asymmetry in RNAi: Function in RISC assembly and gene regulation , 2005, FEBS letters.

[18]  R. Derynck,et al.  TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. , 2001, Genes & development.

[19]  M. Lindsay,et al.  MicroRNAs and the regulation of fibrosis , 2010, The FEBS journal.

[20]  E. White,et al.  PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[21]  D. Guttridge,et al.  MicroRNAs: Novel components in a muscle gene regulatory network , 2009, Cell Cycle.

[22]  Huating Wang,et al.  NF-κB Regulation of YY1 Inhibits Skeletal Myogenesis through Transcriptional Silencing of Myofibrillar Genes , 2007, Molecular and Cellular Biology.

[23]  R. Shiekhattar,et al.  Human RISC Couples MicroRNA Biogenesis and Posttranscriptional Gene Silencing , 2005, Cell.

[24]  M. Sampaolesi,et al.  New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. , 2007, Trends in molecular medicine.

[25]  Huating Wang,et al.  NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. , 2008, Cancer cell.

[26]  Lior Pachter,et al.  Sequence Analysis , 2020, Definitions.

[27]  Nan Deng,et al.  Transcriptome and targetome analysis in MIR155 expressing cells using RNA-seq. , 2010, RNA.

[28]  Yong Li,et al.  Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. , 2002, The American journal of pathology.

[29]  R. Nagatomi,et al.  Notch2 negatively regulates myofibroblastic differentiation of myoblasts , 2007, Journal of cellular physiology.

[30]  J. Qian,et al.  miR-29 is a major regulator of genes associated with pulmonary fibrosis. , 2011, American journal of respiratory cell and molecular biology.

[31]  Oliver Distler,et al.  MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. , 2010, Arthritis and rheumatism.

[32]  Yizheng Li,et al.  Gene expression changes during mouse skeletal myoblast differentiation revealed by transcriptional profiling. , 2002, Physiological genomics.

[33]  Lan-Fang Zhou,et al.  Targeting Fibrosis in Duchenne Muscular Dystrophy , 2010, Journal of neuropathology and experimental neurology.

[34]  Bernard Dan,et al.  Pathophysiology of duchenne muscular dystrophy: current hypotheses. , 2007, Pediatric neurology.

[35]  T. Luedde,et al.  Micro‐RNA profiling reveals a role for miR‐29 in human and murine liver fibrosis , 2011, Hepatology.

[36]  D. Cacchiarelli,et al.  MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. , 2010, Cell metabolism.

[37]  P. Muñoz-Cánoves,et al.  PAI-1–regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy , 2012, The Journal of cell biology.

[38]  K. Davies,et al.  Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment , 2004, EMBO reports.